May 25, 2016
  • New HCV Treatments: High Short-Term Costs,
    Long-Term Savings

    Highly effective new HCV treatments save lives and, in the long run, save money. A series of articles looks at the challenges of funding the therapy over the short term, which would result in substantial mortality reductions and cost savings, more than $800 billion, over 20 years. Here are the details.

  • Statins Lower Risk of Amputation, Death In Peripheral Artery Disease Patients

    Peripheral artery disease patients who can tolerate statins should be placed on high doses of statins to help prevent amputation and early death, according to a new study. Find out how much risk was reduced by the cholesterol-lowering drugs and why dosage matters.

  • How Type 2 Diabetes Trials Disproportionately
    Exclude Younger Women
    How do type 2 diabetes drugs affect pregnant woman? The question is difficult to answer because so many clinical trials exclude women of childbearing age, according to a new study, which sought to document how often those exclusions are really necessary. Here is more information.
  • Pediatrics Hospitals Highly Variable in Use, Overuse
    of Surgical Antibiotics

    In an abundance of caution, many pediatric hospitals dose children with antibiotics before surgery. But when does the abundance become overabundance? That's what a new study sought to determine. Find out how often surgical antibiotic prophylaxis was used unnecessarily.

Connect With U.S. Pharmacist
USP Google AppUSP Itunes App